Narendran A - Search Results

1

Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.

Kariminia A, Ivison SM, Leung VM, Sung S, Couto N, Rozmus J, Rolf N, Narendran A, Dunn SE, Reid GS, Schultz KR. Kariminia A, et al. Among authors: narendran a. Oncol Lett. 2017 Jan;13(1):497-505. doi: 10.3892/ol.2016.5437. Epub 2016 Nov 28. Oncol Lett. 2017. PMID: 28123588 Free PMC article.

2

Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-bone interactions and potential targeted therapeutics.

Jayanthan A, Miettunen PM, Incoronato A, Ortiz-Neira CL, Lewis VA, Anderson R, Frohlich DE, Narendran A. Jayanthan A, et al. Among authors: narendran a. Pediatr Hematol Oncol. 2010 Apr;27(3):212-27. doi: 10.3109/08880011003663382. Pediatr Hematol Oncol. 2010. PMID: 20367265

3

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, Dunn SE. Lee C, et al. Among authors: narendran a. Stem Cells. 2012 Jun;30(6):1064-75. doi: 10.1002/stem.1081. Stem Cells. 2012. PMID: 22415968

4

Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.

Triscott J, Lee C, Foster C, Manoranjan B, Pambid MR, Berns R, Fotovati A, Venugopal C, O'Halloran K, Narendran A, Hawkins C, Ramaswamy V, Bouffet E, Taylor MD, Singhal A, Hukin J, Rassekh R, Yip S, Northcott P, Singh SK, Dunham C, Dunn SE. Triscott J, et al. Among authors: narendran a. Cancer Res. 2013 Nov 15;73(22):6734-44. doi: 10.1158/0008-5472.CAN-12-4331. Epub 2013 Sep 9. Cancer Res. 2013. PMID: 24019381

5

Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells.

Jayanthan A, Hofmann B, Meier-Stephenson V, Perinpanayagam M, Dunn SE, Boklan J, Trippett TM, Truong TH, Narendran A. Jayanthan A, et al. Among authors: narendran a. J Pediatr Hematol Oncol. 2019 Aug;41(6):e359-e370. doi: 10.1097/MPH.0000000000001416. J Pediatr Hematol Oncol. 2019. PMID: 30702467

6

Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.

Hecht A, Meyer JA, Behnert A, Wong E, Chehab F, Olshen A, Hechmer A, Aftandilian C, Bhat R, Choi SW, Chonat S, Farrar JE, Fluchel M, Frangoul H, Han JH, Kolb EA, Kuo DJ, MacMillan ML, Maese L, Maloney KW, Narendran A, Oshrine B, Schultz KR, Sulis ML, Van Mater D, Tasian SK, Hofmann WK, Loh ML, Stieglitz E. Hecht A, et al. Among authors: narendran a. Haematologica. 2022 Jan 1;107(1):178-186. doi: 10.3324/haematol.2020.270595. Haematologica. 2022. PMID: 33375775 Free PMC article.

7

The geldanamycin derivative 17-AAG decreases VEGF secretion and leukemia growth support by trisomy 8 myelodysplastic syndrome bone marrow stromal cells.

Hawkins LM, Narendran A. Hawkins LM, et al. Among authors: narendran a. Pediatr Hematol Oncol. 2005 Mar;22(2):115-25. doi: 10.1080/08880010590896477. Pediatr Hematol Oncol. 2005. PMID: 15804996

8

Effects of Hsp90 inhibition in neuroblastoma: analysis of drug sensitivity, target modulation and the influence of bone marrow microenvironment.

Jayanthan A, Fowler J, Hawkins L, Lamers F, Teja B, Incoronato A, Anderson R, Narendran A. Jayanthan A, et al. Among authors: narendran a. J Exp Ther Oncol. 2008;7(3):183-93. J Exp Ther Oncol. 2008. PMID: 19066127

9

Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.

Jayanthan A, Incoronato A, Singh A, Blackmore C, Bernoux D, Lewis V, Stam R, Whitlock JA, Narendran A. Jayanthan A, et al. Among authors: narendran a. Pediatr Blood Cancer. 2011 Mar;56(3):353-60. doi: 10.1002/pbc.22760. Epub 2010 Nov 28. Pediatr Blood Cancer. 2011. PMID: 21225911

10

Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia.

Mummery A, Narendran A, Lee KY. Mummery A, et al. Among authors: narendran a. Curr Cancer Drug Targets. 2011 Sep;11(7):882-93. doi: 10.2174/156800911796798922. Curr Cancer Drug Targets. 2011. PMID: 21762078 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters